DGX

Quest Diagnostics Incorporated (DGX) ESG Analysis Analysis (2026)

Invetso Score: 6.8/10 — Balanced · Last Updated: 2026-10-01

Environmental

DGX’s environmental profile is mixed because laboratory and diagnostic operations are less emissions-intensive than heavy industry, yet peers still face similar energy, waste, and chemicals-management obligations.

The absence of disclosed R&D intensity in the provided metrics limits evidence of environmental innovation, leaving DGX broadly in line with large healthcare-services peers rather than clearly advantaged.

Operational waste, including regulated medical and laboratory materials, remains a material compliance driver, but DGX’s footprint is typically more manageable than peers with larger manufacturing exposure.

Relative to peers, DGX appears moderately positioned on climate and resource use because its service-based model reduces direct environmental intensity, though it does not eliminate operational ESG risk.

Social

DGX is relatively well positioned on social factors because diagnostic services directly support patient care, access, and public-health outcomes, which are core stakeholder priorities in healthcare.

Low stock-based compensation as a share of revenue suggests limited employee-alignment distortion, supporting a steadier labor profile than peers that rely more heavily on equity incentives.

The business depends on workforce quality, safety, and retention in regulated clinical settings, but these risks are generally comparable to, and often less acute than, peers with more acute-care exposure.

Compared with peers, DGX’s social profile is strengthened by essential healthcare delivery, although service quality, privacy, and workforce compliance remain ongoing operating obligations.

Governance

DGX’s leverage metrics indicate a manageable but meaningful balance-sheet burden, which can constrain governance flexibility relative to peers with stronger capital discipline.

Debt-to-equity and net-debt-to-EBITDA levels are not extreme, but they still require disciplined oversight and increase sensitivity to execution and compliance failures.

The provided metrics show modest stock-based compensation, which reduces dilution concerns and suggests governance practices that are broadly aligned with shareholder interests.

Relative to peers, DGX appears adequately governed rather than exceptional, with no clear evidence here of severe control weaknesses or structural governance advantage.

Overall Score

DGX is moderately positioned overall versus peers, with stronger social characteristics offset by only average environmental and governance profiles.

Score Driver: Essential Healthcare Service Delivery Supports A Stronger Social Profile Than Peers, But Environmental And Governance Positioning Remains Broadly Average.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Quest Diagnostics Incorporated. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →